These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14716710)

  • 21. Weight gain--as possible predictor of metabolic syndrome.
    Grahovac T; Ružić K; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
    Psychiatr Danub; 2011 Mar; 23(1):105-7. PubMed ID: 21448110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test.
    Chen CH; Lin TY; Chen TT; Chen VC; Lin NC; Shao WC; Lu ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):965-9. PubMed ID: 21291941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine.
    Kraus T; Haack M; Schuld A; Hinze-Selch D; Koethe D; Pollmächer T
    Pharmacopsychiatry; 2002 Nov; 35(6):220-5. PubMed ID: 12518269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of baseline body mass index and leptin serum level to the prediction of early weight gain with atypical antipsychotics in schizophrenia.
    Cortés B; Bécker J; Mories Álvarez MT; Marcos AI; Molina V
    Psychiatry Clin Neurosci; 2014 Feb; 68(2):127-32. PubMed ID: 24552633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nizatidine for prevention of weight gain with olanzapine: a double-blind placebo-controlled trial.
    Cavazzoni P; Tanaka Y; Roychowdhury SM; Breier A; Allison DB
    Eur Neuropsychopharmacol; 2003 Mar; 13(2):81-5. PubMed ID: 12650950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain, serum leptin and triglyceride levels in patients with schizophrenia on antipsychotic treatment with quetiapine, olanzapine and haloperidol.
    Atmaca M; Kuloglu M; Tezcan E; Gecici O; Ustundag B
    Schizophr Res; 2003 Mar; 60(1):99-100. PubMed ID: 12505146
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma nitric oxide and leptin values in patients with olanzapine-induced weight gain.
    Atmaca M; Tezcan E; Ustundag B
    J Psychiatr Res; 2007; 41(1-2):74-9. PubMed ID: 16426639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophrenia.
    Biedermann F; Fleischhacker WW; Kemmler G; Ebenbichler CF; Lechleitner M; Hofer A
    Int Clin Psychopharmacol; 2014 May; 29(3):181-4. PubMed ID: 24300751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.
    Rasmussen H; Ebdrup BH; Oranje B; Pinborg LH; Knudsen GM; Glenthøj B
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1729-36. PubMed ID: 24830305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia.
    Brecher M; Leong RW; Stening G; Osterling-Koskinen L; Jones AM
    J Clin Psychiatry; 2007 Apr; 68(4):597-603. PubMed ID: 17474816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia.
    Hansen JM; Bytzer P; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 1998 Mar; 93(3):368-74. PubMed ID: 9517642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with Schizophrenia.
    Tsuneyama N; Suzuki Y; Sawamura K; Sugai T; Fukui N; Watanabe J; Ono S; Saito M; Someya T
    PLoS One; 2016; 11(3):e0149518. PubMed ID: 26930407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of olanzapine-induced weight gain with an increase in body fat.
    Eder U; Mangweth B; Ebenbichler C; Weiss E; Hofer A; Hummer M; Kemmler G; Lechleitner M; Fleischhacker WW
    Am J Psychiatry; 2001 Oct; 158(10):1719-22. PubMed ID: 11579009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of antipsychotic-induced weight gain during quetiapine treatment.
    Koponen H; Larmo I
    Int Clin Psychopharmacol; 2003 Nov; 18(6):355-6. PubMed ID: 14571156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statistically significant increase in weight caused by low-dose quetiapine.
    Williams SG; Alinejad NA; Williams JA; Cruess DF
    Pharmacotherapy; 2010 Oct; 30(10):1011-5. PubMed ID: 20874038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of zonisamide on antipsychotic-associated weight gain in patients with schizophrenia: a randomized, double-blind, placebo-controlled clinical trial.
    Ghanizadeh A; Nikseresht MS; Sahraian A
    Schizophr Res; 2013 Jun; 147(1):110-115. PubMed ID: 23583010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.
    Peuskens J; Link CG
    Acta Psychiatr Scand; 1997 Oct; 96(4):265-73. PubMed ID: 9350955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term remission of schizophrenia in an adolescent treated with quetiapine.
    Hayden F
    J Child Adolesc Psychopharmacol; 2001; 11(3):289-93. PubMed ID: 11642479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma leptin and adiposity during antipsychotic treatment of schizophrenia.
    Haupt DW; Luber A; Maeda J; Melson AK; Schweiger JA; Newcomer JW
    Neuropsychopharmacology; 2005 Jan; 30(1):184-91. PubMed ID: 15367925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.
    Potvin S; Zhornitsky S; Stip E
    Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S26-34. PubMed ID: 25886677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.